Safety Assessment of Lecithin and Other Phosphoglycerides as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 3 9 2021
Statut: ppublish

Résumé

The phosphoglycerides considered in this safety assessment are reported to function primarily as skin and hair conditioning agents, emulsifying agents, and surfactants in cosmetic products and are used up to a maximum reported concentration of 50%. Although phospholipids exert physiologic effects, these are not reproduced by application of phospholipid ingredients to the skin. Given the possibility that Lecithin may be derived from animal sources, it should be noted that the Food and Drug Administration does not permit the use of ingredients made from bovine specified risk materials in cosmetic products. The Expert Panel for Cosmetic Ingredient Safety concluded that the 17 phosphoglycerides are safe in the present practices of use and concentration in cosmetics, as described in this safety assessment.

Identifiants

pubmed: 32975152
doi: 10.1177/1091581820953123
doi:

Substances chimiques

Cosmetics 0
Glycerophospholipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5S-25S

Auteurs

Wilbur Johnson (W)

Cosmetic Ingredient Review Senior Scientific Analyst/Writer.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Member.

Ronald A Hill (RA)

Expert Panel for Cosmetic Ingredient Safety Member.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member.

Daniel C Liebler (DC)

Expert Panel for Cosmetic Ingredient Safety Member.

James G Marks (JG)

Expert Panel for Cosmetic Ingredient Safety Member.

Ronald C Shank (RC)

Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

Expert Panel for Cosmetic Ingredient Safety Member.

Lillian J Gill (LJ)

Cosmetic Ingredient Review Former Director.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH